Invasive Aspergillosis in Children: Where Do We Stand?
|Van der Werff ten Bosch J * and van den Akker M|
|Department of Paediatrics, University Hospital Brussels, Brussels, Belgium|
|Corresponding Author :||van der Werff ten Bosch J
Department of Pediatrics
University Hospital Brussels
Laarbeeklaan 101, 1090 Brussel, Belgium
Tel: +32 2 4774388
Fax: +32 2 4777099
E-mail: [email protected]
|Received August 27, 2014; Accepted October 16, 2014; Published October 31, 2014|
|Citation: Werff JV, Akker MV (2014) Invasive Aspergillosis in Children: Where Do We Stand?. J Infect Dis Ther 2:180. doi:10.4172/2332-0877.1000180|
|Copyright: © 2014 Werff JV, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.|
|Related article at
Pubmed Scholar Google
Invasive opportunistic fungal disease is a well-known complication in immuno deficient patients, adults as well as children. Apart from candida, aspergillus is by far the most common causative agent. Specific guidelines for the pediatric population concerning diagnosis, prophylaxis and treatment of invasive aspergillosis have been published recently and although this has been an important achievement, many challenges remain. This paper gives a short overview of the current guidelines, the recent advances in the diagnosis and management of invasive aspergillosis in the pediatric population. Besides we highlight the unmet needs of the pediatricians who are dealing with patients at risk of this complication.